| EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC | |
| Yin, Yalei; Sun, Mingju; Zhan, Xi; Wu, Changqing; Geng, Pengyu; Sun, Xiaoyan; Wu, Yunsong; Zhang, Shuijun; Qin, Jianhua; Zhuang, Zhengping | |
| 刊名 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
 |
| 2019 | |
| 卷号 | 38 |
| 关键词 | Bromodomain JQ1 MAPK pathway MYC EGFR mutation Sorafenib |
| ISSN号 | 1756-9966 |
| DOI | 10.1186/s13046-019-1082-6 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4218389 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | Yin, Yalei,Sun, Mingju,Zhan, Xi,et al. EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2019,38. |
| APA | Yin, Yalei.,Sun, Mingju.,Zhan, Xi.,Wu, Changqing.,Geng, Pengyu.,...&Liu, Yang.(2019).EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,38. |
| MLA | Yin, Yalei,et al."EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 38(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论